Blood biomarkers may spot ectopic pregnancies early
NCT ID NCT03877939
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at whether certain molecules in the blood (kisspeptins and miRNAs) can help diagnose non-viable pregnancies, including ectopic pregnancies. Researchers collected blood samples from 433 women to measure these biomarkers. The goal is to develop a more accurate and earlier diagnostic test for these dangerous conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to identify non-viable pregnancies early, potentially reducing maternal risks.
- What could go wrong
- This is a completed observational study, not a treatment trial. The biomarkers need further validation before any clinical test becomes available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-VIABLE PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IVI RMA Madrid
Madrid, Madrid, 28023, Spain
-
IVI RMA Seville
Seville, Seville, 41011, Spain